First, this is not a thread for arguing over production efficiency, methods and volumes and/or supply and demand or marketing strategies. Let's negate the future locking of cores too.
Assumptions:
All Phenom II processors come from the same production line, whether or not they end up x2, x3 or x4 core.;
That doesn't equate to all x2 and x3 having 4 stable cores but some do;
We're working with a processor that truly does have enough fault on one or more cores to bin it lower;
Scenarios:
1) The unused core(s) has/have minor faults which would make it wrong to sell as x4 processor
2) The unused core(s) has/have major faults which would make it wrong to sell as anything other than x2 or x3 processor
What are the risks? Are there any steps that can be taken to reduce them?
Thank you for reading. My first post,be gentle =D
Assumptions:
All Phenom II processors come from the same production line, whether or not they end up x2, x3 or x4 core.;
That doesn't equate to all x2 and x3 having 4 stable cores but some do;
We're working with a processor that truly does have enough fault on one or more cores to bin it lower;
Scenarios:
1) The unused core(s) has/have minor faults which would make it wrong to sell as x4 processor
2) The unused core(s) has/have major faults which would make it wrong to sell as anything other than x2 or x3 processor
What are the risks? Are there any steps that can be taken to reduce them?
Thank you for reading. My first post,be gentle =D